Treace Medical Concepts, Inc.

US$4.03As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TMCIHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (31.02%)
Div yield —
ROE (73.98%)
Medical Devices
Beta (5Y) 1.56
PE TTM —
TSR TTM (36.93%)
Mkt cap US$262.1M
ROIC (21.36%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.70
16.51%
(92.72%)
Hold 10|10|9|6|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.05
0.05
0.06
0.06
39.67%
40.04%
37.91%
20.05%
Revenue$M
26.63
27.44
27.15
28.26
5.95%
5.11%
3.15%
9.12%
Peers (US$262.1M)
Cap (US$)
PE
274.2M
31.10x
249.7M
1.861x
Capital
TTM
5Y
10Y
Leveragex
1.300
4.270
3.646
EBIT/Intx
3.591
0.740
0.585
Own earn%
(44.32)
(60.55)
(81.71)
Sh yield%
38.77
31.03
35.87
Owners
Insiders/Inst%
6.25
44.15
Short interest%
1.33
SBC / revenue%
4.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
12–19
$1 testx
—
Incr. ROIC%
4